Home
Primrose Bio

Primrose Bio Market Share Analysis for May 2026

At Cytiva’s Process Development Summit, Primrose Bio showcased a high-throughput enzyme screening method using Protein Select™ and Pfenex Expression Technology®.

Industry: N/A

Domainprimrosebio.com

Year Founded2023

Employees51 - 200

Annual Revenue--

Primrose Bio

Primrose Bio (including company regionals)

primrosebio.com

See more website traffic and engagement information

Total visits to Primrose Bio's top domains

Understand Primrose Bio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

primrosebio.com4.1K

See more with Sales Intelligence

Avg. visit duration in Primrose Bio's top domains

Analyze Primrose Bio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

primrosebio.com00:02:51

See more with Sales Intelligence

Avg. pageviews on Primrose Bio's top domains

See how Primrose Bio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

primrosebio.com2.60

See more with Sales Intelligence

Primrose Bio top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Primrose Bio

These are the website technologies, by industry, used by Primrose Bio top domains

Payment & Currencies (8)

Cart Functionality

Advertising (6)

Google Adsense

Widget (6)

reCAPTCHA

Audio Video Media (3)

YouTube

More Technologies

10

See all

News & Signals from Primrose Bio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIntravacc partnered with Primordial Genetics Inc. on Jun 1st '26.BILTHOVEN, The Netherlands, June 01, 2026 - Intravacc, a leading global contract development and manufacturing organization (CDMO) specializing in infectious disease and therapeutic vaccines and biologics, and Primrose Bio, a biotechnology company with leading technologies that improve the manufacturing of next-generation therapeutics, renew their strategic partnership to enhance the development and supply of conjugate vaccines.

NewsPrimordial Genetics Inc. launched Prima RNApols ExTend Cap AU on Nov 10th '25.Nov. 10, 2025 - Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, today announced the launch of Prima RNApols(TM) ExTend Cap AU, an RNA polymerase engineered to significantly improve manufacturing of self-amplifying mRNA vaccines and therapeutics.

NewsPrimordial Genetics Inc. is developing novel multi-antigen vaccine for infections on Jan 10th '25.Primrose Bio, Inc. ("Primrose"), a company with proprietary manufacturing technologies for human therapeutics, and Serum Institute of India Pvt. Ltd. ("SIIPL"), the world's largest vaccine manufacturer, today announced a collaboration to develop a novel multi-antigen vaccine for infections that affect millions of people globally.